View Item 

Show simple item record

Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
dc.contributor.authorLópez‐medrano, F.
dc.contributor.authorFernández‐ruiz, M.
dc.contributor.authorSilva, J. T.
dc.contributor.authorCarver, P. L.
dc.contributor.authorDelden, C.
dc.contributor.authorMerino, E.
dc.contributor.authorPérez‐saez, M. J.
dc.contributor.authorMontero, M.
dc.contributor.authorCoussement, J.
dc.contributor.authorAbreu Mazzolin, M.
dc.contributor.authorCervera, C.
dc.contributor.authorSantos, L.
dc.contributor.authorSabé, N.
dc.contributor.authorScemla, A.
dc.contributor.authorCordero, E.
dc.contributor.authorCruzado‐vega, L.
dc.contributor.authorMartín‐moreno, P. L.
dc.contributor.authorLen, Ó.
dc.contributor.authorRudas, E.
dc.contributor.authorLeón, A. P.
dc.contributor.authorArriola, M.
dc.contributor.authorLauzurica, R.
dc.contributor.authorDavid, M.
dc.contributor.authorGonzález‐rico, C.
dc.contributor.authorHenríquez‐palop, F.
dc.contributor.authorFortún, J.
dc.contributor.authorNucci, M.
dc.contributor.authorManuel, O.
dc.contributor.authorPaño‐pardo, J. R.
dc.contributor.authorMontejo, M.
dc.contributor.authorMuñoz, P.
dc.contributor.authorSánchez‐sobrino, B.
dc.contributor.authorMazuecos, A.
dc.contributor.authorPascual, J.
dc.contributor.authorHorcajada, J. P.
dc.contributor.authorLecompte, T.
dc.contributor.authorMoreno, A.
dc.contributor.authorCarratalà, J.
dc.contributor.authorBlanes, M.
dc.contributor.authorHernández, D.
dc.contributor.authorFariñas, M. C.
dc.contributor.authorAndrés, A.
dc.contributor.authorAguado, J. M.
dc.date.accessioned2016-11-18T21:23:44Z
dc.date.available2018-01-08T19:47:52Zen
dc.date.issued2016-11
dc.identifier.citationLópez‐medrano, F. ; Fernández‐ruiz, M. ; Silva, J. T.; Carver, P. L.; Delden, C.; Merino, E.; Pérez‐saez, M. J. ; Montero, M.; Coussement, J.; Abreu Mazzolin, M.; Cervera, C.; Santos, L.; Sabé, N. ; Scemla, A.; Cordero, E.; Cruzado‐vega, L. ; Martín‐moreno, P. L. ; Len, Ó. ; Rudas, E.; León, A. P. ; Arriola, M.; Lauzurica, R.; David, M.; González‐rico, C. ; Henríquez‐palop, F. ; Fortún, J. ; Nucci, M.; Manuel, O.; Paño‐pardo, J. R. ; Montejo, M.; Muñoz, P. ; Sánchez‐sobrino, B. ; Mazuecos, A.; Pascual, J.; Horcajada, J. P.; Lecompte, T.; Moreno, A.; Carratalà, J. ; Blanes, M.; Hernández, D. ; Fariñas, M. C. ; Andrés, A. ; Aguado, J. M. (2016). "Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study." American Journal of Transplantation 16(11): 3220-3234.
dc.identifier.issn1600-6135
dc.identifier.issn1600-6143
dc.identifier.urihttps://hdl.handle.net/2027.42/134453
dc.publisherWiley Periodicals, Inc.
dc.subject.otherclinical research/practice
dc.subject.otherinfectious disease
dc.subject.otherkidney transplantation/nephrology
dc.subject.otherantibiotic: antifungal
dc.subject.othercomplication: infectious
dc.subject.otherinfection and infectious agents
dc.subject.otherfungal
dc.titleClinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134453/1/ajt13837.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134453/2/ajt13837_am.pdf
dc.identifier.doi10.1111/ajt.13837
dc.identifier.sourceAmerican Journal of Transplantation
dc.identifier.citedreferencePerezâ Saez MJ, Mir M, Montero MM, et al. Invasive aspergillosis in kidney transplant recipients: A cohort study. Exp Clin Transplant 2014; 12: 101 â 105.
dc.identifier.citedreferenceWingard JR, Ribaud P, Schlamm HT, Herbrecht R. Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 2008; 112: 2309 â 2312.
dc.identifier.citedreferenceMarr KA, Schlamm HT, Herbrecht R, et al. Combination antifungal therapy for invasive aspergillosis: A randomized trial. Ann Intern Med 2015; 162: 81 â 89.
dc.identifier.citedreferenceWojtowicz A, Gresnigt MS, Lecompte T, et al. IL1B and DEFB1 polymorphisms increase susceptibility to invasive mold infection after solidâ organ transplantation. J Infect Dis 2015; 211: 1646 â 1657.
dc.identifier.citedreferenceKoller MT, van Delden C, Muller NJ, et al. Design and methodology of the Swiss Transplant Cohort Study (STCS): A comprehensive prospective nationwide longâ term followâ up cohort. Eur J Epidemiol 2013; 28: 347 â 355.
dc.identifier.citedreferenceMuñoz P, Valerio M, Palomo J, et al. Targeted antifungal prophylaxis in heart transplant recipients. Transplantation 2013; 96: 664 â 669.
dc.identifier.citedreferenceHeylen L, Maertens J, Naesens M, et al. Invasive aspergillosis after kidney transplant: Caseâ control study. Clin Infect Dis 2015; 60: 1505 â 1511.
dc.identifier.citedreferenceSahin SZ, Akalin H, Ersoy A, et al. Invasive fungal infections in renal transplant recipients: Epidemiology and risk factors. Mycopathologia 2015; 180: 43 â 50.
dc.identifier.citedreferenceSantos T, Aguiar B, Santos L, et al. Invasive fungal infections after kidney transplantation: A singleâ center experience. Transplant Proc 2015; 47: 971 â 975.
dc.identifier.citedreferenceAbbott KC, Hypolite I, Poropatich RK, et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001; 3: 203 â 211.
dc.identifier.citedreferenceMorgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: Interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43 ( Suppl 1 ): S49 â S58.
dc.identifier.citedreferenceBaddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50: 1559 â 1567.
dc.identifier.citedreferenceMontagna MT, Lovero G, Coretti C, et al. SIMIFF study: Italian fungal registry of mold infections in hematological and nonâ hematological patients. Infection 2014; 42: 141 â 151.
dc.identifier.citedreferenceXu H, Li L, Huang WJ, Wang LX, Li WF, Yuan WF. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: A case control study from China. Clin Microbiol Infect 2012; 18: 403 â 408.
dc.identifier.citedreferenceTaccone FS, Van den Abeele AM, Bulpa P, et al. Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes. Crit Care 2015; 19: 7.
dc.identifier.citedreferenceSingh N, Husain S; AST Infectious Diseases Community of Practice. Aspergillosis in solid organ transplantation. Am J Transplant 2013; 13 ( Suppl 4 ): 228 â 241.
dc.identifier.citedreferenceGavaldà J, Meije Y, Fortun J, et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 2014; 20 ( Suppl 7 ): 27 â 48.
dc.identifier.citedreferenceGavaldà J, Len à , San Juan R, et al. Risk factors for invasive aspergillosis in solidâ organ transplant recipients: A caseâ control study. Clin Infect Dis 2005; 41: 52 â 59.
dc.identifier.citedreferenceCornet M, Fleury L, Maslo C, Bernard JF, Brucker G; Invasive Aspergillosis Surveillance Network of the Assistance Publiqueâ Hopitaux de P. Epidemiology of invasive aspergillosis in France: A sixâ year multicentric survey in the Greater Paris area. J Hosp Infect 2002; 51: 288 â 296.
dc.identifier.citedreferenceLortholary O, Gangneux JP, Sitbon K, et al. Epidemiological trends in invasive aspergillosis in France: The SAIF network (2005â 2007). Clin Microbiol Infect 2011; 17: 1882 â 1889.
dc.identifier.citedreferenceGlobal observatory on donation and transplantation. 2012 activity data. 2012 [cited 2015 Sep 20]. Available from: http://www.transplant-observatory.org/Pages/Data-Reports.aspx.
dc.identifier.citedreferencePappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: Results of the Transplantâ Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101 â 1111.
dc.identifier.citedreferenceNeofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12: 220 â 229.
dc.identifier.citedreferenceNeofytos D, Treadway S, Ostrander D, et al. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: A 10â year, singleâ center experience. Transpl Infect Dis 2013; 15: 233 â 242.
dc.identifier.citedreferenceBodro M, Sabe N, Gomila A, et al. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients. Transplant Proc 2012; 44: 2682 â 2685.
dc.identifier.citedreferenceConcato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. J Clin Epidemiol 1995; 48: 1495 â 1501.
dc.identifier.citedreferenceSingh N, Limaye AP, Forrest G, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: A prospective, multicenter, observational study. Transplantation 2006; 81: 320 â 326.
dc.identifier.citedreferenceRao KV, Ma J. Chronic viral hepatitis enhances the risk of infection but not acute rejection in renal transplant recipients. Transplantation 1996; 62: 1765 â 1769.
dc.identifier.citedreferenceBruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renalâ replacement therapy, and outcome after kidney transplantation. Transplantation 2004; 78: 745 â 750.
dc.identifier.citedreferenceFabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001; 38: 919 â 934.
dc.identifier.citedreferenceDomínguezâ Gil B, Morales JM. Transplantation in the patient with hepatitis C. Transpl Int 2009; 22: 1117 â 1131.
dc.identifier.citedreferenceBellmann R. Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis. Curr Pharm Des 2013; 19: 3629 â 3647.
dc.identifier.citedreferenceBarchiesi F, Mazzocato S, Mazzanti S, et al. Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases. Liver Transpl 2015; 21: 204 â 212.
dc.identifier.citedreferenceMuñoz P, Cerón I, Valerio M, et al. Invasive aspergillosis among heart transplant recipients: A 24â year perspective. J Heart Lung Transplant 2014; 33: 278 â 288.
dc.identifier.citedreferenceGallagher JC, Dodds Ashley ES, Drew RH, Perfect JR. Antifungal pharmacotherapy for invasive mould infections. Expert Opin Pharmacother 2003; 4: 147 â 164.
dc.identifier.citedreferenceSingh N, Winston DJ, Limaye AP, et al. Performance characteristics of galactomannan and betaâ dâ glucan in highâ risk liver transplant recipients. Transplantation 2015; 99: 2543 â 2550.
dc.identifier.citedreferencePfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: A metaâ analysis. Clin Infect Dis 2006; 42: 1417 â 1427.
dc.identifier.citedreferenceNivoix Y, Velten M, Letscherâ Bru V, et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47: 1176 â 1184.
dc.identifier.citedreferenceLim C, Seo JB, Park SY, et al. Analysis of initial and followâ up CT findings in patients with invasive pulmonary aspergillosis after solid organ transplantation. Clin Radiol 2012; 67: 1179 â 1186.
dc.identifier.citedreferenceKuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985; 157: 611 â 614.
dc.identifier.citedreferenceAustin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46: 399 â 424.
dc.identifier.citedreferenceAustin PC, Tu JV. Bootstrap methods for developing predictive models. Am Stat 2004; 58: 131 â 137.
dc.identifier.citedreferenceLevey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461 â 470.
dc.identifier.citedreferenceEuropean Expert Group on Renal Transplantation (EBPG); European Renal Association (ERAâ EDTA); European Society for Organ Transplantation (ESOT). European Best Practice Guidelines for renal transplantation (part 1). Nephrol Dial Transplant 2000; 15 ( Suppl 7 ): 1 â 85.
dc.identifier.citedreferenceHumar A, Michaels M; AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262 â 274.
dc.identifier.citedreferenceMuñoz P, Vena A, Ceron I, et al. Invasive pulmonary aspergillosis in heart transplant recipients: Two radiologic patterns with a different prognosis. J Heart Lung Transplant 2014; 33: 1034 â 1040.
dc.identifier.citedreferenceDe Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813 â 1821.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajt13837.pdf
Size:
170.9KB
Format:
PDF
View/Open
Name:
ajt13837_am.pdf
Size:
296.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.